1.7
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Premarket
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Vaxart Inc | VXRT | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.0% | 1.70 | 0.00 | 0.00 | 0.00 | 1.70 | 04:02:38 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 1.70 | 1.72 | 0.02 | 1.16% | - | - |
| Stock Trades | Traded Volume | Average Volume | 52 Week Range |
|---|---|---|---|
| 1 | 20 | 11,588,167 | 0.2543 - 3.97 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 04:29:11 | 20 | $ 1.70 | USD |
Vaxart Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 120.25M | 70.73M | $ -18.01M | -0.79 | - | 67.98M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | 3.90% |
Vaxart News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VXRT Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.80 | 2.10 | 1.60 | 1.72 | 3,222,556 | -0.10 | -5.56% |
| 1 Month | 2.97 | 3.45 | 1.08 | 2.05 | 7,158,160 | -1.27 | -42.76% |
| 3 Months | 0.355 | 3.97 | 0.344 | 1.66 | 11,626,315 | 1.35 | 378.87% |
| 6 Months | 0.36 | 3.97 | 0.266 | 1.61 | 5,564,750 | 1.34 | 372.22% |
| 1 Year | 1.92 | 3.97 | 0.2543 | 1.52 | 3,115,944 | -0.22 | -11.46% |
| 3 Years | 6.60 | 11.88 | 0.2543 | 2.21 | 1,298,389 | -4.90 | -74.24% |
| 5 Years | 25.74 | 29.26 | 0.2543 | 2.74 | 802,055 | -24.04 | -93.4% |
Vaxart Description
| Vaxart Inc is a biopharmaceutical company. It is focused on the discovery and development of direct-acting antivirals to treat infections that affect patients globally. The company has three product candidates which are; Influenza, Norovirus and RSV Vaccine, an oral fusion protein inhibitor for the treatment and prevention of respiratory syncytial virus (RSV) infections, and BTA074, a topical antiviral treatment in for condyloma caused by human papillomavirus. |
